• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Japan·Industrials·3110.T
Share

Nitto Boseki Co., Ltd. Stocks

¥ 2679Last Updated 13.11.2026

Issuer Rating

4/7
Performance

Strong

Risk

High

Recommendation

Hold

Market Cap

¥ 2.76B

¥ 2679
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Solid dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Nitto Boseki Co., Ltd., headquartered in Tokyo, Japan, is a company with a rich history, having been founded in 1918 as Fukusima Seiren Seishi K.K. and adopting its current name in April 1923. The organization operates across multiple sectors, specializing in the production, processing, and distribution of a diverse range of products. Its core activities encompass textiles, including various apparel items like women's interlinings, stretch fabrics, and other functional textiles, as well as industrial textile goods. The company is also a significant provider of glass fiber products, which are utilized in automotive applications, smartphone casing composites, high-performance electronic substrates, resin-coated film materials, and house insulation. Furthermore, Nitto Boseki's portfolio extends to rock wool and building materials, along with specialty chemicals and medical solutions. In the medical domain, it develops reagents for in vitro diagnostics within biochemistry, hematology, and immunology. Its chemical division focuses on creating functional polymers for numerous industrial applications. Beyond these primary areas, the company manufactures PET bottles and soft drinks. It is also involved in construction project planning, supervision, and contracting, alongside the design, manufacturing, and marketing of machinery and equipment.

Company Valuation

Fairly valued
4/7

Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Favourable
6/7

The average target price of 3110.T is 4605 and suggests 73.5% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to in

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

15.11.2026 03:32

SpaceX has successfully caught Starship with its capture tower for the first time. What does this mean for the stock?

14.11.2026 17:01

What's New in Small-Cap Stocks: The Forbes Ranking, Oklo's Plans for Meta, and Ceco's Record

14.11.2026 13:01

Is There Life After Huang? The Rise of Anthropic, and the AI Rally in the Clouds

14.11.2026 04:56

Key Starship tests did not go as planned. SpaceX shares fell

14.11.2026 04:35

The S&P 500 posted its best week in six months. Barclays expects growth for the first time since March

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026